Back
ProShares UltraShort Real Estate Vs. Dyne Therapeutics Industry Stock Comparison
Sell
27
SRS
ProShares UltraShort Real Estate
Last Price:
48.02
Seasonality Move:
-10.56%
Buy
66
DYN
Dyne Therapeutics
Last Price:
30.40
Seasonality Move:
38.02%
Sell
27
ProShares UltraShort Real Estate (SRS)
is a Sell
Is ProShares UltraShort Real Estate a Buy, Sell or Hold?
- The current ProShares UltraShort Real Estate [SRS] share price is $47.31. The Score for SRS is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.
- SRS is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
66
Dyne Therapeutics (DYN)
is a Buy
Is Dyne Therapeutics a Buy, Sell or Hold?
- The current Dyne Therapeutics [DYN] share price is $34.14. The Score for DYN is 66, which is 32% above its historic median score of 50, and infers lower risk than normal.
- DYN is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
SRS Stock Price Chart
What is ProShares UltraShort Real Estate's stock price today?
-
The ProShares UltraShort Real Estate share price today is $47.31
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SRS is experiencing slight buying pressure.
DYN Stock Price Chart
What is Dyne Therapeutics's stock price today?
-
The Dyne Therapeutics share price today is $34.14
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and DYN is experiencing buying pressure, which is a positive indicator for future bullish movement.
SRS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.34 | Buy |
| Relative Strength Index (14 RSI): | 52.15 | Buy |
| Chaikin Money Flow: | 5984 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (45.19 - 47.73) | Buy |
| Bollinger Bands (100): | (44.8 - 55.24) | Sell |
DYN Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.99 | Sell |
| Relative Strength Index (14 RSI): | 60.64 | Buy |
| Chaikin Money Flow: | 1192325 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (28.99 - 33.51) | Buy |
| Bollinger Bands (100): | (31.49 - 42.59) | Sell |
SRS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 47.33 | Sell |
| 20-day SMA: | 46.53 | Buy |
| 50-day SMA: | 46.02 | Buy |
| 200-day SMA: | 56.64 | Sell |
| 8-day EMA: | 47.26 | Buy |
| 20-day EMA: | 46.85 | Buy |
| 50-day EMA: | 47.32 | Sell |
| 200-day EMA: | 55.09 | Sell |
DYN Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 29.58 | Buy |
| 20-day SMA: | 30.81 | Buy |
| 50-day SMA: | 32.62 | Buy |
| 200-day SMA: | 32.06 | Buy |
| 8-day EMA: | 30.24 | Buy |
| 20-day EMA: | 30.74 | Buy |
| 50-day EMA: | 32.95 | Buy |
| 200-day EMA: | 30.83 | Buy |
ProShares UltraShort Real Estate Earnings Growth & SRS Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Dyne Therapeutics Earnings Growth & DYN Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.54 per share, and an increase next year of $0.08 per share.
ProShares UltraShort Real Estate Technical Analysis
| Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Dyne Therapeutics Technical Analysis
| Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||